Bristol Myers Squibb (BMY) Current Deferred Revenue (2009 - 2026)
Bristol Myers Squibb (BMY) reported Current Deferred Revenue of $168.0 million for Q1 2026, down 22.58% year-over-year from $217.0 million in Q1 2025, and down 4.0% on a QoQ basis from $175.0 million in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Current Deferred Revenue data on file, last reported at $168.0 million in Q1 2026.
- Quarterly Current Deferred Revenue fell 22.58% year-over-year to $168.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $168.0 million (down 22.58% YoY) and the FY2025 annual result came in at $175.0 million, up 27.74% from the prior year.
- Current Deferred Revenue retreated to $168.0 million in Q1 2026 per BMY's latest filing, from $175.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $326.0 million in Q1 2022 and bottomed at $137.0 million in Q4 2024.
- The 5-year median for Current Deferred Revenue is $263.0 million (2024), against an average of $250.2 million.
- The widest annual swing landed in 2024, when Current Deferred Revenue slumped 50.0%; it then increased 27.74% in 2025.
- Tracing BMY's Current Deferred Revenue over 5 years: stood at $289.0 million in 2022, then dropped by 5.19% to $274.0 million in 2023, then tumbled by 50.0% to $137.0 million in 2024, then gained by 27.74% to $175.0 million in 2025, then slipped by 4.0% to $168.0 million in 2026.
- Per Business Quant, the three latest BMY Current Deferred Revenue figures stand at $168.0 million (Q1 2026), $175.0 million (Q4 2025), and $190.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 168.00 Mn |
| Dec 31, 2025 | 175.00 Mn |
| Sep 30, 2025 | 190.00 Mn |
| Jun 30, 2025 | 203.00 Mn |
| Mar 31, 2025 | 217.00 Mn |
| Dec 31, 2024 | 137.00 Mn |
| Sep 30, 2024 | 236.00 Mn |
| Jun 30, 2024 | 248.00 Mn |
| Mar 31, 2024 | 263.00 Mn |
| Dec 31, 2023 | 274.00 Mn |
| Sep 30, 2023 | 289.00 Mn |
| Jun 30, 2023 | 300.00 Mn |
| Mar 31, 2023 | 314.00 Mn |
| Dec 31, 2022 | 289.00 Mn |
| Sep 30, 2022 | 304.00 Mn |
| Jun 30, 2022 | 321.00 Mn |
| Mar 31, 2022 | 326.00 Mn |
| Dec 31, 2021 | 330.00 Mn |
| Sep 30, 2021 | 344.00 Mn |
| Jun 30, 2021 | 349.00 Mn |
| Mar 31, 2021 | 367.00 Mn |
| Dec 31, 2020 | 366.00 Mn |
| Sep 30, 2020 | 392.00 Mn |
| Jun 30, 2020 | 411.00 Mn |
| Mar 31, 2020 | 432.00 Mn |
| Dec 31, 2019 | 431.00 Mn |
| Mar 31, 2019 | 103.00 Mn |
| Dec 31, 2018 | 172.00 Mn |
| Sep 30, 2018 | 93.00 Mn |
| Jun 30, 2018 | 88.00 Mn |
| Mar 31, 2018 | 117.00 Mn |
| Dec 31, 2017 | 83.00 Mn |
| Sep 30, 2017 | 647.00 Mn |
| Jun 30, 2017 | 737.00 Mn |
| Mar 31, 2017 | 837.00 Mn |
| Dec 31, 2016 | 762.00 Mn |
| Sep 30, 2016 | 1.89 Bn |
| Jun 30, 2016 | 1.77 Bn |
| Mar 31, 2016 | 1.17 Bn |
| Dec 31, 2015 | 1.00 Bn |
| Sep 30, 2015 | 1.59 Bn |
| Jun 30, 2015 | 1.61 Bn |
| Mar 31, 2015 | 2.16 Bn |
| Dec 31, 2014 | 1.94 Bn |
| Sep 30, 2014 | 995.00 Mn |
| Jun 30, 2014 | 2.13 Bn |
| Mar 31, 2014 | 2.13 Bn |
| Dec 31, 2013 | 756.00 Mn |
| Sep 30, 2013 | 5.20 Bn |
| Jun 30, 2013 | 986.00 Mn |
| Mar 31, 2013 | 772.00 Mn |
| Dec 31, 2012 | 4.85 Bn |
| Sep 30, 2012 | 689.00 Mn |
| Jun 30, 2012 | 503.00 Mn |
| Mar 31, 2012 | 287.00 Mn |
| Dec 31, 2011 | 1.20 Bn |
| Sep 30, 2011 | 321.00 Mn |
| Jun 30, 2011 | 283.00 Mn |
| Mar 31, 2011 | 347.00 Mn |
| Dec 31, 2010 | 402.00 Mn |
| Dec 31, 2009 | 237.00 Mn |
| Sep 30, 2009 | 276.00 Mn |
| Jun 30, 2009 | 267.00 Mn |